Scientific and clinical expertise: A strong background in the life sciences, ideally with experience in neurodegenerative diseases, is crucial. This would enable the CEO to understand the complexities of drug development and the potential hurdles in clinical trials.
Regulatory navigation: Experience with the FDA and other regulatory bodies is essential for guiding the company through the approval process for its drug candidates.
Capital management: The ability to effectively allocate capital is key to ensuring the company can fund its development programs, manage cash burn, and make strategic decisions about the pipeline.
Investor relations: A strong track record of communicating with investors, including both institutional and retail shareholders, is important for managing stock performance and ensuring adequate funding.
Commercialization strategy: The CEO should have experience in commercializing a product, whether it's through building a sales force or forming strategic partnerships to bring the drug to market.
Market Data 
Markets 
AI
